Ellagic acid - Revision history

Lazy at 08:20, 18 January 2025

2025-01-18T08:20:11Z

← Older revision		Revision as of 01:20, 18 January 2025
Line 71:		Line 71:
	\|links=		\|links=
	\|toxicity_explanation=Ellagic Acid, derived from fruits and nuts, is generally considered safe due to its natural origins. It has not been documented to cause specific side effects. However, it's important to note it's still in preclinical and early trial phases, with a focus on cancer prevention rather than treatment. A toxicity level of 1 signifies that it has not been associated with severe harm or side effects, though more extensive clinical research is needed.		\|toxicity_explanation=Ellagic Acid, derived from fruits and nuts, is generally considered safe due to its natural origins. It has not been documented to cause specific side effects. However, it's important to note it's still in preclinical and early trial phases, with a focus on cancer prevention rather than treatment. A toxicity level of 1 signifies that it has not been associated with severe harm or side effects, though more extensive clinical research is needed.
	}}		\|overview=Ellagic Acid, a naturally occurring compound found in fruits and nuts, is being investigated for its potential anti-cancer properties, particularly in the context of cancer prevention and treatment, although it is not FDA-approved for these uses. While laboratory studies show promise, including an increase in PSA doubling time in a prostate cancer trial, further clinical research is necessary to establish its efficacy and safety in oncology.}}

69.163.248.232: Updated category= to treatment_category= in TreatmentInfo template

2024-11-12T18:30:10Z

Updated category= to treatment_category= in TreatmentInfo template

← Older revision		Revision as of 11:30, 12 November 2024
Line 9:		Line 9:
	\|usefulness_rating=3		\|usefulness_rating=3
	\|notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.		\|notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.
	\|~~category~~=Nutraceuticals		\|treatment_category=Nutraceuticals
	\|book_text=Ellagic Acid		\|book_text=Ellagic Acid

Lazy at 18:09, 27 March 2024

2024-03-27T18:09:57Z

← Older revision		Revision as of 11:09, 27 March 2024
Line 9:		Line 9:
	\|usefulness_rating=3		\|usefulness_rating=3
	\|notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.		\|notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.
	\|category=Nutraceuticals ~~and Herbals~~		\|category=Nutraceuticals
	\|book_text=Ellagic Acid		\|book_text=Ellagic Acid

Lazy at 16:54, 27 March 2024

2024-03-27T16:54:44Z

← Older revision		Revision as of 09:54, 27 March 2024
Line 70:		Line 70:
	\|toxicity_level=1		\|toxicity_level=1
	\|links=		\|links=
			\|toxicity_explanation=Ellagic Acid, derived from fruits and nuts, is generally considered safe due to its natural origins. It has not been documented to cause specific side effects. However, it's important to note it's still in preclinical and early trial phases, with a focus on cancer prevention rather than treatment. A toxicity level of 1 signifies that it has not been associated with severe harm or side effects, though more extensive clinical research is needed.
	}}		}}

Lazy at 08:48, 26 March 2024

2024-03-26T08:48:46Z

@@ Line 10: / Line 10: @@
 |notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.
 |category=Nutraceuticals and Herbals
 |links=
 }}

Lazy: Created page with "{{TreatmentInfo |drug_name=Ellagic Acid |FDA_approval=No (Utilized as a dietary component; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer prevention and treatment; noted for potential anti-cancer properties in laboratory studies |clinical_trial_phase=Preclinical and early clinical trials (e.g., prostate cancer study at UCLA) |common_side_effects=Not specifically documented; as a naturally occurring compound in fruits and nuts, it is genera..."

2024-03-21T12:36:15Z

Created page with "{{TreatmentInfo |drug_name=Ellagic Acid |FDA_approval=No (Utilized as a dietary component; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer prevention and treatment; noted for potential anti-cancer properties in laboratory studies |clinical_trial_phase=Preclinical and early clinical trials (e.g., prostate cancer study at UCLA) |common_side_effects=Not specifically documented; as a naturally occurring compound in fruits and nuts, it is genera..."

New page

{{TreatmentInfo
|drug_name=Ellagic Acid
|FDA_approval=No (Utilized as a dietary component; not FDA-approved for cancer treatment)
|used_for=Investigational use in cancer prevention and treatment; noted for potential anti-cancer properties in laboratory studies
|clinical_trial_phase=Preclinical and early clinical trials (e.g., prostate cancer study at UCLA)
|common_side_effects=Not specifically documented; as a naturally occurring compound in fruits and nuts, it is generally considered safe
|OS_with=Not applicable; current research focuses on biochemical effects and prevention metrics like PSA doubling time in prostate cancer
|PFS_with=Not applicable; direct impacts on progression-free survival in cancer patients are not yet established
|usefulness_rating=3
|notes=Ellagic Acid, found in various fruits and nuts, exhibits anti-cancer properties in laboratory experiments, including the inhibition of cell division and induction of apoptosis. Although clinical trials specific to brain cancer are lacking, a study with prostate cancer patients demonstrated that pomegranate juice, rich in ellagitannins (ellagic acid precursors), significantly slowed the increase in PSA levels, suggesting a potential for cancer management. These findings indicate ellagic acid's promise in cancer prevention and warrant further clinical investigation to confirm its efficacy and therapeutic application in oncology.
|category=Nutraceuticals and Herbals
|links=
}}